argenx SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell argenx SE and other ETFs, options, and stocks.

About ARGX

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China.

CEO

Tim van Hauwermeiren

CEOTim van Hauwermeiren

Employees

1,599

Employees1,599

Headquarters

Amsterdam, Noord-Holland

HeadquartersAmsterdam, Noord-Holland

Founded

2008

Founded2008

Employees

1,599

Employees1,599

ARGX Key Statistics

Market cap

50.48B

Market cap50.48B

Price-Earnings ratio

37.04

Price-Earnings ratio37.04

Dividend yield

—

Dividend yield—

Average volume

340.18K

Average volume340.18K

High today

$799.87

High today$799.87

Low today

$770.67

Low today$770.67

Open price

$782.02

Open price$782.02

Volume

456.62K

Volume456.62K

52 Week high

$934.62

52 Week high$934.62

52 Week low

$510.06

52 Week low$510.06

ARGX News

TipRanks 4h

Argenx Advances Combo Strategy in Myasthenia Gravis With New ADAPT Forward Study

Argenx (ARGX) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium ADAPT Forward 1 (NCT07284420) is a Phase 2a proof-of-concept...

TipRanks 11h

Argenx reports preliminary Q4 revenue $1.29B, consensus $1.1B

Reports preliminary FY25 revenue $4.15B, consensus $3.59B. “Argenx (ARGX) enters 2026 in a position of strength, delivering meaningful impact to approximately 1...

TipRanks 6d

argenx: Leadership Continuity and Pipeline Milestones Underpin Sustained Buy Rating and $1,006 Price Target

In a report released yesterday, Tazeen Ahmad from Bank of America Securities maintained a Buy rating on Argenx Se, with a price target of $1,006.00. Claim 70% O...

Analyst ratings

86%

of 28 ratings

Buy

85.7%

Hold

10.7%

Sell

3.6%